196 related articles for article (PubMed ID: 28706272)
1. Modeling Atrial Fibrillation using Human Embryonic Stem Cell-Derived Atrial Tissue.
Laksman Z; Wauchop M; Lin E; Protze S; Lee J; Yang W; Izaddoustdar F; Shafaattalab S; Gepstein L; Tibbits GF; Keller G; Backx PH
Sci Rep; 2017 Jul; 7(1):5268. PubMed ID: 28706272
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of I
Juhász V; Hornyik T; Benák A; Nagy N; Husti Z; Pap R; Sághy L; Virág L; Varró A; Baczkó I
Can J Physiol Pharmacol; 2018 Jan; 96(1):18-25. PubMed ID: 28892643
[TBL] [Abstract][Full Text] [Related]
3. "Early" class III drugs for the treatment of atrial fibrillation: efficacy and atrial selectivity of AVE0118 in remodeled atria of the goat.
Blaauw Y; Gögelein H; Tieleman RG; van Hunnik A; Schotten U; Allessie MA
Circulation; 2004 Sep; 110(13):1717-24. PubMed ID: 15364815
[TBL] [Abstract][Full Text] [Related]
4. Potassium Channel Blockade Enhances Atrial Fibrillation-Selective Antiarrhythmic Effects of Optimized State-Dependent Sodium Channel Blockade.
Aguilar M; Xiong F; Qi XY; Comtois P; Nattel S
Circulation; 2015 Dec; 132(23):2203-11. PubMed ID: 26499964
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of KCB-328, a new IKr blocking antiarrhythmic agent in pacing induced canine atrial fibrillation.
Chandra P; Rosen TS; Yeom ZH; Lee K; Kim HY; Danilo P; Rosen MR
Europace; 2004 Sep; 6(5):384-91. PubMed ID: 15294262
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Cultured Human Cardiomyocyte Clusters Obtained from Embryos/Fetuses or Derived from Human Embryonic Stem Cells.
Grubb S; Vestergaard ML; Andersen AS; Rasmussen KK; Mamsen LS; Tuckute G; Grunnet-Lauridsen K; Møllgård K; Ernst E; Christensen ST; Calloe K; Andersen CY
Stem Cells Dev; 2019 May; 28(9):608-619. PubMed ID: 30755084
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of IKr potentiates development of atrial-selective INa block leading to effective suppression of atrial fibrillation.
Burashnikov A; Belardinelli L; Antzelevitch C
Heart Rhythm; 2015 Apr; 12(4):836-44. PubMed ID: 25546810
[TBL] [Abstract][Full Text] [Related]
8. Cardioversion of persistent atrial fibrillation by a combination of atrial specific and non-specific class III drugs in the goat.
Blaauw Y; Schotten U; van Hunnik A; Neuberger HR; Allessie MA
Cardiovasc Res; 2007 Jul; 75(1):89-98. PubMed ID: 17466958
[TBL] [Abstract][Full Text] [Related]
9. Ionic determinants of functional reentry in a 2-D model of human atrial cells during simulated chronic atrial fibrillation.
Pandit SV; Berenfeld O; Anumonwo JM; Zaritski RM; Kneller J; Nattel S; Jalife J
Biophys J; 2005 Jun; 88(6):3806-21. PubMed ID: 15792974
[TBL] [Abstract][Full Text] [Related]
10. Synergistic Effect of Dofetilide and Mexiletine on Prevention of Atrial Fibrillation.
Liu G; Xue X; Gao C; Huang J; Qi D; Zhang Y; Dong JZ; Ma CS; Yan GX
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28522677
[TBL] [Abstract][Full Text] [Related]
11. [Perspectives and limitations in the treatment of vagus-induced atrial fibrillation. Insights from cellular pharmacology].
Brandts B; Van Bracht M; Dirkmann D; Borchard R; Wickenbrock I; Prull MW; Meine M; Trappe HJ
Med Klin (Munich); 2004 Jul; 99(7):341-6. PubMed ID: 15322712
[TBL] [Abstract][Full Text] [Related]
12. Atrial-like cardiomyocytes from human pluripotent stem cells are a robust preclinical model for assessing atrial-selective pharmacology.
Devalla HD; Schwach V; Ford JW; Milnes JT; El-Haou S; Jackson C; Gkatzis K; Elliott DA; Chuva de Sousa Lopes SM; Mummery CL; Verkerk AO; Passier R
EMBO Mol Med; 2015 Apr; 7(4):394-410. PubMed ID: 25700171
[TBL] [Abstract][Full Text] [Related]
13. Chloroquine terminates stretch-induced atrial fibrillation more effectively than flecainide in the sheep heart.
Filgueiras-Rama D; Martins RP; Mironov S; Yamazaki M; Calvo CJ; Ennis SR; Bandaru K; Noujaim SF; Kalifa J; Berenfeld O; Jalife J
Circ Arrhythm Electrophysiol; 2012 Jun; 5(3):561-70. PubMed ID: 22467674
[TBL] [Abstract][Full Text] [Related]
14. Effects of the selective KACh channel blocker NTC-801 on atrial fibrillation in a canine model of atrial tachypacing: comparison with class Ic and III drugs.
Yamamoto W; Hashimoto N; Matsuura J; Machida T; Ogino Y; Kobayashi T; Yamanaka Y; Ishiwata N; Yamashita T; Tanimoto K; Miyoshi S; Fukuda K; Nakaya H; Ogawa S
J Cardiovasc Pharmacol; 2014 May; 63(5):421-7. PubMed ID: 24805146
[TBL] [Abstract][Full Text] [Related]
15. Anti-arrhythmic effects of I (Na), I (Kr), and combined I (Kr)-I (CaL) blockade in an experimental model of acute stretch-related atrial fibrillation.
Kalifa J; Bernard M; Gout B; Bril A; Cozma D; Laurent P; Chalvidan T; Deharo JC; Djiane P; Cozzone P; Maixent JM
Cardiovasc Drugs Ther; 2007 Feb; 21(1):47-53. PubMed ID: 17356910
[TBL] [Abstract][Full Text] [Related]
16. Characterization of in vivo and in vitro electrophysiological and antiarrhythmic effects of a novel IKACh blocker, NIP-151: a comparison with an IKr-blocker dofetilide.
Hashimoto N; Yamashita T; Tsuruzoe N
J Cardiovasc Pharmacol; 2008 Feb; 51(2):162-9. PubMed ID: 18287884
[TBL] [Abstract][Full Text] [Related]
17. Ultrarapid Delayed Rectifier K
Hilderink S; Devalla HD; Bosch L; Wilders R; Verkerk AO
Front Cell Dev Biol; 2020; 8():536. PubMed ID: 32850774
[TBL] [Abstract][Full Text] [Related]
18. Human stem cell-derived cardiomyocytes detect drug-mediated changes in action potentials and ion currents.
Gibson JK; Yue Y; Bronson J; Palmer C; Numann R
J Pharmacol Toxicol Methods; 2014; 70(3):255-67. PubMed ID: 25219538
[TBL] [Abstract][Full Text] [Related]
19. Antiarrhythmic effect of vernakalant in electrically remodeled goat atria is caused by slowing of conduction and prolongation of postrepolarization refractoriness.
van Hunnik A; Lau DH; Zeemering S; Kuiper M; Verheule S; Schotten U
Heart Rhythm; 2016 Apr; 13(4):964-72. PubMed ID: 26681610
[TBL] [Abstract][Full Text] [Related]
20. Rate-Dependent Role of I
Aguilar M; Feng J; Vigmond E; Comtois P; Nattel S
Biophys J; 2017 May; 112(9):1997-2010. PubMed ID: 28494969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
